Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,459 signal articles · 145 in last 24h · 154,156 total before filter · latest 1h ago
145last 24h
874last 7d
145● bullish (7d)
96● bearish (7d)
214publishers
AllMacro211Earnings107M&A125Regulatory21Product21Analyst17
✕ clear all filtersticker: MRNASentiment:bullishneutralbearishshow all (incl. clickbait)
Biotech Investors Are Tuning Out the MAHA Chaos
The Wall Street Journal127d agoneutral
Biotech Investors Are Tuning Out the MAHA Chaos

The Food and Drug Administration is rudderless. Its commissioner, Marty Makary, is gone. The rise of the Make America Healthy Again movement, with its vaccine skepticism and adversarial stance toward drugmakers, has hung over biotech since Robert F. Kennedy Jr. took over at the Department of Health and Human Services.

Stocks Settle Higher on Strong Earnings
Barchart136d agoneutral
Stocks Settle Higher on Strong Earnings

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.19%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.29%. June E-mini S&P futures (ESM26 ) rose +0.18%, and June E-mini Nasdaq futures...

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates
Barrons.com142d agobullish
Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates

Pfizer shares rose slightly in premarket trading after the company delivered a first-quarter earnings beat and reaffirmed its full-year outlook. The drugmaker posted adjusted earnings of 75 cents a share, ahead of the 72 cents Wall Street had forecast. Pfizer reaffirmed its full-year guidance, which it initially provided in December.